Projects overview

Sort by

Toggle all information

ADVANTAGE | ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach

01-07-2015

-

31-03-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

LAUREN | bLadder cAncer URine cEll aNalysis

01-06-2015

-

31-07-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

Calcivis CAIS | Validation of clinical performance and pre-commercial development of a novel diagnostic for dental caries assessment

01-07-2015

-

30-06-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

RABIOPRED | RABIOPRED - Clinical validation of BIOmarker assay to PREDict treatment response in Rheumatoid Arthritis (RA) patients

01-07-2015

-

31-12-2018

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

RapidEx | Validation of a point-of-care H-FABP test for a rapid exclusion of Acute Myocardial Infarction in patients with cardiac complaints.

01-04-2015

-

31-10-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

LEONID | Lung cancEr fusiOn geNes: a new dIagnostic Device

01-07-2015

-

31-12-2016

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

GLIOMARK | Validation of blood-brain-barrier permeability as a glioma biomarker by means of the radiotracer 99mTc-tetrofosmin and single-photon emission computer tomography

01-07-2015

-

31-12-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices

SIME-LMT | Development of a digital diagnostics rapid Lung Maturity Test (LMT) for premature infants, to assist neonatologists in the diagnosis of Respiratory Distress Syndrome at birth

01-04-2015

-

31-03-2017

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices
Powered by Chris Decubber BV